Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19.

Dementia and neurocognitive disorders Pub Date : 2021-04-01 Epub Date: 2021-04-08 DOI:10.12779/dnd.2021.20.2.13

Yu Min Kang, Noh Hyuck Park, Min Jae Seong, Hyun Jeong Han, Young Hee Jung

{"title":"Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19.","authors":"Yu Min Kang, Noh Hyuck Park, Min Jae Seong, Hyun Jeong Han, Young Hee Jung","doi":"10.12779/dnd.2021.20.2.13","DOIUrl":null,"url":null,"abstract":"A 67-year-old-male was hospitalised for COVID-19-associated-pneumonia on April 2, 2020. His first symptoms consisted of myalgia and a cough. COVID-19 was diagnosed based on the detection of SARS-CoV-2 viral nucleic acid through a nasopharyngeal swab specimen using real-time polymerase-chain-reaction assay. Chest computerised tomography showed patchy areas of consolidation in the peribronchial and subpleural areas of both lungs, which was consistent with COVID-19-associated-pneumonia. He had diabetes, chronic kidney disease without dialysis, and alcoholic liver disease. The patient was not a smoker, but a heavy drinker. Lopinavir/ritonavir and antibiotic therapy were initiated. On the 5th day of illness, the patient was intubated due to desaturation. On the 14th day, multi-organ failure was diagnosed, and continuous-renal-replacement-therapy and extracorporeal-membraneoxygenation were administered. On the 25th day, he was released from quarantine due to the negative results of three consecutive COVID-19-tests. He had stupor, but diffusion, and MRI showed no abnormal findings. The response was not improved until 42nd day, although sedative was not used.","PeriodicalId":72779,"journal":{"name":"Dementia and neurocognitive disorders","volume":"20 2","pages":"13-15"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/0b/dnd-20-13.PMC8093011.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and neurocognitive disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12779/dnd.2021.20.2.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

A 67-year-old-male was hospitalised for COVID-19-associated-pneumonia on April 2, 2020. His first symptoms consisted of myalgia and a cough. COVID-19 was diagnosed based on the detection of SARS-CoV-2 viral nucleic acid through a nasopharyngeal swab specimen using real-time polymerase-chain-reaction assay. Chest computerised tomography showed patchy areas of consolidation in the peribronchial and subpleural areas of both lungs, which was consistent with COVID-19-associated-pneumonia. He had diabetes, chronic kidney disease without dialysis, and alcoholic liver disease. The patient was not a smoker, but a heavy drinker. Lopinavir/ritonavir and antibiotic therapy were initiated. On the 5th day of illness, the patient was intubated due to desaturation. On the 14th day, multi-organ failure was diagnosed, and continuous-renal-replacement-therapy and extracorporeal-membraneoxygenation were administered. On the 25th day, he was released from quarantine due to the negative results of three consecutive COVID-19-tests. He had stupor, but diffusion, and MRI showed no abnormal findings. The response was not improved until 42nd day, although sedative was not used.

Abstract Image